Abstract
To improve the tissue penetration efficiency (PE%) of hydrophilic-drugs in non-vascular drug eluting stents (DES), we designed photochemical tissue penetration (PTP) invested DES (PTP-DES). The PTP technology was applied to the stent as a covering membrane to generate singlet oxygen. Singlet oxygen damages the epithelial layer, so the PE% of released drugs could be improved. To prepare the PTP-DES membrane, chlorin e6 (Ce6, photosensitizer) was incorporated in a gemcitabine (GEM) eluting polyurethane (PU) membrane (Ce6-GEM-PU). Ce6-GEM-PU has smooth surface that is ~40μm thick. The photoactivity of Ce6 was maintained for 2 weeks (invitro GEM releasing period). In a separate cell culture system, both 1.5 folds higher PE% and an improved tumor cell growth inhibition effect were shown after light exposure. Additionally, in tissue penetration experimental system, 2 folds increased in the PE% of GEM was induced by laser exposure at 80J/cm2. Additionally, improved PE% of hydrophilic molecules (Fluorescein and GEM) was confirmed in colon tumor bearing mice. Consequentially, tumor growth, when implanted with Ce6-GEM-PU, was effectively inhibited without significant side effects. Based on these results, we believe that the PTP-DES system has great potential for improving the therapeutic effect of conventional DES.
| Original language | English |
|---|---|
| Pages (from-to) | 484-493 |
| Number of pages | 10 |
| Journal | Biomaterials |
| Volume | 52 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2015 |
Bibliographical note
Publisher Copyright:© 2015 Elsevier Ltd.
Keywords
- Drug eluting stent
- Epithelial junction
- Gemcitabine
- Photochemical tissue penetration
Fingerprint
Dive into the research topics of 'Photochemical tissue penetration via photosensitizer for effective drug penetration in a non-vascular tumor'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver